Goelzer Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-74,976
| Closed | -$2.72M | – | 202 |
|
|
2016
Q4 | $2.72M | Buy |
74,976
+7,636
| +11% | +$277K | 0.35% | 106 |
|
|
2016
Q3 | $3.1M | Buy |
67,340
+4,685
| +7% | +$216K | 0.42% | 101 |
|
|
2016
Q2 | $3.15M | Buy |
62,655
+1,362
| +2% | +$68.4K | 0.43% | 96 |
|
|
2016
Q1 | $3.28M | Buy |
61,293
+1,214
| +2% | +$65K | 0.47% | 93 |
|
|
2015
Q4 | $3.94M | Buy |
60,079
+3,680
| +7% | +$242K | 0.58% | 64 |
|
|
2015
Q3 | $3.18M | Buy |
56,399
+908
| +2% | +$51.3K | 0.51% | 85 |
|
|
2015
Q2 | $3.28M | Buy |
55,491
+59
| +0.1% | +$3.49K | 0.5% | 88 |
|
|
2015
Q1 | $3.45M | Buy |
55,432
+115
| +0.2% | +$7.16K | 0.52% | 85 |
|
|
2014
Q4 | $3.18M | Buy |
55,317
+4,731
| +9% | +$272K | 0.48% | 98 |
|
|
2014
Q3 | $2.72M | Sell |
50,586
-370
| -0.7% | -$19.9K | 0.45% | 103 |
|
|
2014
Q2 | $2.67M | Buy |
50,956
+835
| +2% | +$43.8K | 0.44% | 108 |
|
|
2014
Q1 | $2.65M | Sell |
50,121
-779
| -2% | -$41.2K | 0.47% | 96 |
|
|
2013
Q4 | $2.04M | Sell |
50,900
-2,323
| -4% | -$93.1K | 0.37% | 116 |
|
|
2013
Q3 | $2.01M | Sell |
53,223
-53,663
| -50% | -$2.03M | 0.41% | 107 |
|
|
2013
Q2 | $4.19M | Buy |
+106,886
| New | +$4.19M | 0.45% | 103 |
|